|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1725 I Street NW, Suite 900 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26422-24
|
||||||||
|
6. House ID# 302590000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Tamara Chrisler |
Date | 4/21/2024 9:23:57 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Federal courts and judicial nominees;
Support for the continued confirmation of judges committed to civil and human rights;
Nomination of Nicole Berner to the U.S. Court of Appeals for the Fourth Circuit;
Nomination of Adeel Mangi to the U.S. Court of Appeals for the Third Circuit;
Support for Supreme Court ethics reform and expansion.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
|
Emily |
McDowell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY24 appropriations for Departments of Labor, Health and Human Services, and Education, and related agencies, including the Hyde amendment, the Weldon amendment, increased funding for Title X, zeroing out abstinence only education, increasing funding for the Teen Pregnancy Prevention Program, funding for entities that offer abortion care, and abortion-related executive orders;
FY24 appropriations for Department of State, Foreign Operations, and Related Programs, including the Helms amendment, the Hyde amendment, increased funding for international family planning and reproductive health programs, increased funding for UNFPA, ending the Kemp-Kasten amendment, and the Livingston amendment;
FY24 appropriations for Military Construction, Veterans Affairs, and Related Agencies, including veterans access to abortion services;
FY24 appropriations for Department Agriculture, Rural Development, Food and Drug Administration, including FDA approval of mifepristone;
FY24 appropriations for Department of Homeland Security, coverage and provision of abortion services for individuals in ICE custody;
FY24 appropriations for Department of Defense, access to abortion services and gender affirming care for servicemembers and their dependents;
FY24 appropriations for Financial Services and General Government, reproductive freedom attacks aimed at the District of Columbia, bans on abortion coverage for federal employees, denials of coverage for contraceptive care and supplies;
FY25 appropriations for Department of State, Foreign Operations, and Related Programs, including the Helms amendment, the Hyde amendment, increased funding for international family planning and reproductive health programs, increased funding for UNFPA, ending the Kemp-Kasten amendment, and the Livingston amendment;
FY25 budget and appropriations re sexual and reproductive health, including Title X family planning program, Medicaid Free Choice of Provider, and Teen Pregnancy Prevention Program.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Reproductive healthcare in FY24 and 25 federal spending bills and the presidential budget;
Reproductive Rights and Roe v. Wade and Dobbs v. Jackson Womens Health Organization;
H.R.6914 the Pregnant Students Rights Act;
Funding for fake health center/crisis pregnancy centers, including H.R.6918 the Supporting Pregnant and Parenting Women and Families Act;
the Abortion Care Capacity Enhancement and Support Services (ACCESS) Act, which would provide financial support to ease access to reproductive health care;
Assisted Reproductive Technology, including IVF;
H.R.7056 and S.3612, the Access to Family Building Act;
H.Res.1043, purporting to support assisted reproductive technologies;
Federal issues related to state abortion bans and abortion access in the United States;
Administrative actions to protect and expand abortion access;
Child tax credit;
Access to contraception and the right to contraception, including the Right to Contraception Act;
Access to and affordability of contraceptives, including those available OTC;
LGBTQI+ rights;
Title IX;
H.R. 7187, the Protection of Women in Olympic and Amateur Sports Act;
Discrimination against LGBTQI+ people;
Bans and restrictions on gender affirming care;
Access to evidence-based medication abortion care;
Issues related Alliance for Hippocratic (AHM) v. FDA;
Issues related to discrimination and mistreatment of pregnant people, including implementation of the Pregnant Workers Fairness Act;
Paid Family and Medical Leave, including H.R.3481 and S.1714 the FAMILY Act;
Labor protections, including Fair Labor Standards Act, that disproportionately impact women;
Data and health records privacy as it relates to abortion care, including in relation to reauthorization of FISA sec. 702.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |